iBio, Inc. Common Stock (IBIO) support and resistance · rev $100.0K
iBio, Inc. Common Stock (IBIO) is a biotechnology company listed on US.
This page maps iBio, Inc. Common Stock (IBIO) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported IBIO revenue for 2026-06-30 was $100.0K. Net income was -$32.8M. Revenue was down 75.0% from 2025-06-30 to 2026-06-30. IBIO currently screens at market cap $13.4M.
IBIO currently screens at market cap $13.4M. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new IBIO 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the IBIO quote page for the session range and the stock page for the full model.
Not investment advice.